• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Severity of emphysema on pulmonary CT may predict lung cancer location

byDavid WangandDylan Wolman
September 2, 2015
in Imaging and Intervention, Oncology, Pulmonology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In a retrospective review of over 190 patients with primary lung cancers, patients with lower grade emphysema and airway-predominant disease as determined by pulmonary computed tomography had a significantly higher frequency of central lung cancers as compared to patients with severe emphysema.

Evidence Rating Level: 3 (Average)       

Study Rundown: Chronic obstructive pulmonary disease (COPD) is a progressive condition characterized by both chronic bronchitis, or abnormal small airway inflammatory response, and emphysema, the parenchymal destruction of alveoli. COPD is directly related to smoking exposure and subsequently, lung carcinogenesis. However, there has been a paucity of data regarding the relationship between emphysema severity and the anatomical location of primary lung cancers in affected patients. This retrospective review analyzed over 190 lung cancer patients with COPD for tumor location and emphysema severity as assed by pulmonary CT imaging. At the conclusion of the trial, lower emphysema grades (0-2) were associated with a four-fold greater risk of centrally located lung tumors as compared to patients with severe emphysema (grade 4). This association remained after adjusting for age, smoking extent, and performance on spirometry. The results of this article support the hypothesis that COPD is a heterogeneous disease with varying spectrum of small-airway destruction and that emphysema severity may preferentially affect distal airways leading to peripheral lung cancer. The results also support the increased use of thin-section screening CT, bronchoscopy or sputum cytology for a subset of patients with lower-grade emphysema given its increased sensitivity for central lung cancers.  The study is limited by the relatively small sample size and the retrospective study design. Additional large prospective trials are needed to confirm this association, and to determine if the suggested additional screening methodologies may reduce the time-to-diagnosis in these patients.

Click to read the study in AJR

Relevant Reading: Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans 

In-Depth [retrospective review]: In this retrospective study, the graded severity of emphysema was compared to the location of known lung cancers in patients with or without concurrent COPD. The study analyzed 405 patients with pathologically proven primary lung cancer from two academic hospitals in South Korea from 2010 to 2014. Patients with pulmonary fibrosis were excluded given their independent risk factor for peripheral lung cancers. Of the 405 included patients, 198 had COPD and 207 did not have COPD. Each group’s respective mean age was 67.6±7.1 and 63.6±10.4, and the COPD group was predominantly male at 96.5%, while the group without COPD was only 47.3% male. Grading of emphysema on CT was performed by two independent readers according to the criteria delineated by the National Emphysema Treatment Trial. Two additional, blinded readers determined if tumors were peripherally or centrally located. At the conclusion of the trial, patients with COPD had a significantly higher risk of central lung cancer as compared to non-COPD patients (36.4% vs. 17.4%; p< 0.001). However, in patients with COPD, lower emphysema grades were negatively associated with central location (OR: 0.69; 95% CI: 0.51-0.93; p = 0.016).  This association remained after multivariate regression adjustments for age, smoking, and spirometry results.

RELATED REPORTS

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Computed Tomography (CT)emphysemalung cancer
Previous Post

Spiritual considerations not addressed by health care professionals in ICUs

Next Post

Government-funded initiatives provide important supports to low-income HIV patients

RelatedReports

Lessons from real-world implementation of lung cancer screening
Oncology

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

July 7, 2025
#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

July 4, 2025
Patient Basics: Lung Cancer Overview
Chronic Disease

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

July 2, 2025
#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
StudyGraphics

#VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

June 19, 2025
Next Post
Government-funded initiatives provide important supports to low-income HIV patients

Government-funded initiatives provide important supports to low-income HIV patients

CHADS-VASc score may help predict outcomes in heart failure

CHADS-VASc score may help predict outcomes in heart failure

Rate of weight loss may not affect long-term weight control

First-born sisters more likely to be overweight or obese compared to their younger sisters

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.